In human breast cancer cells, MDA-MB-231, the use of 2-APB or silencing of TRPM7 with siRNA significantly decreases intracellular calcium, resulting in total inhibition of mineralization, strongly suggesting a functional role for the channel in the development of hydroxyapatite crystals [131]. Here, TRPM7 is linked to breast carcinoma.